pyrroles has been researched along with pregabalin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kanai, M; Mita, T; Sasaki, K; Shibasaki, M | 1 |
Guo, Z; Zhao, H | 1 |
Lee, CH; Liou, HH | 1 |
Di Cesare Mannelli, L; Farina, C; Ghelardini, C; Maresca, M; Micheli, L; Scherz, MW | 1 |
Carlisle, B; Federico, CA; Kimmelman, J | 1 |
1 review(s) available for pyrroles and pregabalin
Article | Year |
---|---|
Medicinal chemistry strategies in follow-on drug discovery.
Topics: Animals; Atorvastatin; Bendamustine Hydrochloride; Benzazepines; Chemistry, Pharmaceutical; Clinical Trials as Topic; Drug Delivery Systems; Drug Discovery; gamma-Aminobutyric Acid; Heptanoic Acids; Humans; Lapatinib; Nitrogen Mustard Compounds; Pregabalin; Pyrimidines; Pyrroles; Quinazolines; Sulfonamides | 2009 |
4 other study(ies) available for pyrroles and pregabalin
Article | Year |
---|---|
Catalytic enantioselective conjugate addition of cyanide to alpha,beta-unsaturated N-acylpyrroles.
Topics: Catalysis; Cinnamates; Cyanides; Gadolinium; gamma-Aminobutyric Acid; Organometallic Compounds; Pregabalin; Pyrroles; Stereoisomerism | 2005 |
Pregabalin activates ROMK1 channels via cAMP-dependent protein kinase and protein kinase C.
Topics: Analgesics; Animals; Anticonvulsants; Carbazoles; Cyclic AMP-Dependent Protein Kinases; Female; gamma-Aminobutyric Acid; Isoquinolines; Oocytes; Potassium Channels, Inwardly Rectifying; Pregabalin; Protein Kinase C; Protein Kinase Inhibitors; Pyrroles; Sulfonamides; Xenopus laevis | 2014 |
A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin.
Topics: Administration, Oral; Animals; Disease Models, Animal; Duloxetine Hydrochloride; Fluorouracil; Humans; Imidazoles; Neuralgia; Pregabalin; Pyrroles; Rats; Rats, Sprague-Dawley | 2017 |
Trials that say "maybe": the disconnect between exploratory and confirmatory testing after drug approval.
Topics: Antineoplastic Agents; Calcium Channel Blockers; Clinical Trials as Topic; Drug Approval; Drug Industry; Humans; Indoles; Niacinamide; Phenylurea Compounds; Pregabalin; Pyrroles; Sorafenib; Sunitinib | 2018 |